Astrazeneca (AZNCF) Current Taxes (2016 - 2025)
Historic Current Taxes for Astrazeneca (AZNCF) over the last 16 years, with Q4 2025 value amounting to -$1.1 billion.
- Astrazeneca's Current Taxes fell 55301.2% to -$1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.1 billion, marking a year-over-year decrease of 55301.2%. This contributed to the annual value of -$1.1 billion for FY2025, which is 55301.2% down from last year.
- Latest data reveals that Astrazeneca reported Current Taxes of -$1.1 billion as of Q4 2025, which was down 55301.2% from -$1.3 billion recorded in Q3 2025.
- Astrazeneca's Current Taxes' 5-year high stood at $1.6 billion during Q4 2023, with a 5-year trough of -$1.7 billion in Q1 2025.
- Over the past 5 years, Astrazeneca's median Current Taxes value was -$800.5 million (recorded in 2022), while the average stood at -$533.4 million.
- Per our database at Business Quant, Astrazeneca's Current Taxes surged by 25468.63% in 2021 and then plummeted by 55301.2% in 2025.
- Astrazeneca's Current Taxes (Quarter) stood at $916.0 million in 2021, then fell by 2.18% to $896.0 million in 2022, then soared by 76.79% to $1.6 billion in 2023, then crashed by 110.48% to -$166.0 million in 2024, then crashed by 553.01% to -$1.1 billion in 2025.
- Its last three reported values are -$1.1 billion in Q4 2025, -$1.3 billion for Q3 2025, and -$1.2 billion during Q2 2025.